Oncophage® patient-specific cancer vaccine
An investigational product
Oncophage news
| Date |
Title (click to view the full text) |
| April 8, 2008 | Oncophage® Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer |
| February 20, 2008 | Antigenics Announces Publication of Phase 3 Melanoma Study Results in Journal of Clinical Oncology |
| October 25, 2007 | Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics |
| October 10, 2007 | First Patient Registered in Investigator-Sponsored Phase 2 Trial of Antigenics’ Oncophage Cancer Vaccine in Glioma |
| August 2, 2007 | Antigenics Provides Update on Filing for Approval of Oncophage® in Russia for the Treatment of Intermediate-Risk Kidney Cancer |
| May 21, 2007 | Oncophage® Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer |
| April 16, 2007 | Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting |
| November 16, 2006 | Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at Immunotherapy Task Force Meeting at the Society of Neuro-Oncology’s Annual Meeting |
| June 7, 2006 | Antigenics Announces Results From In-Depth Analysis of Phase 3 Data of Oncophage in Kidney Cancer and Provides Regulatory Update |
| June 5, 2006 | Antigenics Presents Phase 3 Data From Trial of Oncophage in Metastatic Melanoma at ASCO Meeting |
| March 24, 2006 | Antigenics Reports Phase 3 Results for Oncophage in Kidney Cancer |
| November 21, 2005 | First Patient Enrolled in Investigator-Sponsored Phase 1/2 Trial of Antigenics’ Oncophage Cancer Vaccine in Glioma |
| October 10, 2005 | Antigenics Announces Preliminary Survival Data From Its Randomized Phase 3 Metastatic Melanoma Trial |
| June 7, 2005 | Antigenics’ Oncophage Cancer Vaccine Receives European Orphan Drug Designation for Renal Cell Carcinoma |
| June 7, 2004 | Phase 3 Demographic Data on Antigenics’ Oncophage Cancer Vaccine in Kidney Cancer Published at ASCO Meeting |
|
|
